Incidence, impact and natural history of Klebsiella species infections in cystic fibrosis: A longitudinal single center study

References

• Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154(5):1229–1256.
   Web of Science ®Google Scholar
• Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918–951.
   PubMed Web of Science ®Google Scholar
• Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15(2):194–222.
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Ratjen F, Stephens D, et al. Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros. 2013;12(6):575–583.
   Web of Science ®Google Scholar
• Dasenbrook EC. Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. Curr Opin Pulm Med. 2011;17(6):437–441.
   Web of Science ®Google Scholar
• Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros. 2015;14(3):293–304.
   PubMed Web of Science ®Google Scholar
• Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162(16):1849–1858.
   PubMedGoogle Scholar
• Kang CI, Song JH, Oh WS, Ko KS, Chung DR, Peck KR. Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2008;27(8):657–661.
   Web of Science ®Google Scholar
• Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8(2):160–166.
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25(10):860–867.
   PubMed Web of Science ®Google Scholar
• Lin YT, Jeng YY, Chen TL, Fung CP. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis. 2010;10:307.
   PubMed Web of Science ®Google Scholar
• Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122(9):866–873.
   PubMed Web of Science ®Google Scholar
• Delfino E, Giacobbe DR, Del Bono V, et al. First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis. J Clin Microbiol. 2015;53(4):1442–1444.
   Web of Science ®Google Scholar
• Leao RS, Pereira RH, Folescu TW, et al. KPC-2 carbapenemase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis. J Cyst Fibros. 2011;10(2):140–142.
   PubMed Web of Science ®Google Scholar
• Steinkamp G, Wiedemann B, Rietschel E, et al. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros. 2005;4(1):41–48.
   PubMedGoogle Scholar
• Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest. 2004;125(1):1s–39s.
   Web of Science ®Google Scholar
• Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2(1):29–34.
   PubMedGoogle Scholar
• Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994;331(10):637–642.
   PubMed Web of Science ®Google Scholar
• Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. BMC Infect Dis. 2015;15:145
   Web of Science ®Google Scholar
• Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 2006;42(10):1351–1358.
   PubMed Web of Science ®Google Scholar
• Barry AL, Coyle MB, Thornsberry C, Gerlach EH, Hawkinson RW. Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test. J Clin Microbiol. 1979;10(6):885–889.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–2239.
   PubMed Web of Science ®Google Scholar
• Stock I, Wiedemann B. Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol. 2001;50(5):396–406.
   Web of Science ®Google Scholar
• Maeda Y, Elborn JS, Parkins MD, et al. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros. 2011;10(2):133–139.
   Web of Science ®Google Scholar
• Burke DG, Fouhy F, Harrison MJ, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol. 2017;17(1):58.
   PubMedGoogle Scholar
• Sibley CD, Grinwis ME, Field TR, et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One. 2011;6(7):e22702.
   PubMed Web of Science ®Google Scholar
• Goss CH, Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros: Off J Eur Cyst Fibros Soc. 2011;10(5):298–306.
   PubMed Web of Science ®Google Scholar